FOLH1 and neoplasm: Although PSMA-617 alone does not induce death of tumour cells in our experimental setting, it significantly potentiates the cell death-promoting effect of 177Lu-PSMA-617 in LNCaP cells at concentrations which do not reduce the binding of 177Lu-PSMA-617.